- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02522676
Evaluation of Different Treatment Modalities for Lower Pole and Renal Pelvis Stones
Comparison of Success Rates, Complication Rates and Injury to Kidneys of Conventional PCNL, Mini PCNL, Ultra-mini PCNL, Micro PCNL, RIRS and ESWL in the Treatment of Lower Pole and Renal Pelvis Stone(s)
Study Overview
Status
Conditions
Detailed Description
In this study, the demographic and preoperative data, imaging data, operative data and postoperative follow-up data will be prospectively recorded according to the patient information forms for the patients with lower pole and/or renal pelvis stone(s) who will undergo either one of the treatment modalities including conventional PCNL, mini PCNL, ultra-mini PCNL, micro PCNL, RIRS and ESWL.
A total of 300 (three hundred) patients, aging between 18 and 70 years, with similar stone size and location are being planned to be enrolled into the study; and will be prospectively randomized into one of six groups with a 1:1 ratio. By this means, conventional PCNL will performed to 50 (fifty) patients, mini PCNL will be performed to 50 (fifty) patients, ultra-mini PCNL will be performed to 50 (fifty) patients, micro PCNL will be performed to 50 (fifty) patients, while 50 (fifty) patients will undergo RIRS and 50 (fifty) patients will undergo ESWL.
Preoperatively, blood Cystatin C and Netrin-1, and urine Neutrophil gelatinase-associated lipocalin (NGAL), Cystatin C and Netrin-1 levels will be measured. After the treatments, blood Cystatin C and Netrin-1 levels at postoperative 6th, 12th, 24th and 48th hours will be recorded. Cystatin C and Netrin-1 levels in urine will be measured at postoperative 12th and 24th hours, while urine NGAL levels will be measured at postoperative 12th and 72nd hours. Besides these, classical kidney function tests, namely blood urea and creatinine levels, will be measured preoperatively and postoperatively at 24th and 48th hours.
Parameters listed below will be also recorded and evaluated:
- Preoperative general evaluation data: Age, height, weight, body-mass index, concomitant comorbidities, prescriptions used, history of operation(s), American Society of Anesthesiologists (ASA) score
- Preoperative urological evaluation data: History of ESWL/PCNL/ureterorenoscopy (URS)/RIRS/open surgery, whole blood count, kidney function tests, automatic urine test, urine culture, preoperative imaging modality (KUB, US, CT), number-dimensions-localization-composition of stone(s), existence of hydronephrosis
- Operative data: Access fluoroscopy duration, total access duration, total fluoroscopy duration, operation duration, use of double-J stent, preoperative complications
- Number of previous ESWL seance, total duration of ESWL, number of shots during ESWL (if any)
- Follow-up data: Urethral catheterization time, hospitalization time, need of any other treatment for being stone-free, time to full stone-free, duration to removal of double-J stent, existence of residual stone(s), formation of new stone(s), complications in late time, medical prophylaxis
- Stone analysis
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Konya, Turkey, 42075
- Selcuk University, School of Medicine, Department of Urology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients planned to undergo either conventional PCNL, mini PCNL, ultra-mini PCNL, micro PCNL, RIRS or ESWL due to kidney stone(s)
- Patients between 18 and 70 years old
Exclusion Criteria:
- Patients with unregulated diabetes mellitus and diabetic nephropathy
- Patients with a blood pressure higher than 140/80 mmHg despite use of antihypertensive drug(s) regularly
- Patients with chronic renal failure who need dialysis
- Patients who had prerenal, renal or postrenal acute kidney failure during the last 6 months
- Patients who had acute pyelonephritis during the last 6 months
- Patients younger than 18 years old or older than 70 years old
- Patients who had kidney surgery during the last 3 months and who have abnormal kidney functions
- Patients with ureteral stone who are planned to undergo endoscopic stone treatment at the same time
- Patients with a history of corticosteroid use during enrollment into the study or previous 3 months
- Patients with uncontrolled thyroid disease
- Patients who have a disease with rapid cell turn-over (like leukemia, lymphoma, etc.)
- Patients in whom PCNL/RIRS/ESWL cannot be performed due to any reason and the procedure is terminated
- Patients who are converted to open surgery due to any reason
- Patients with missing data
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional PCNL
Endoscopic kidney stone surgery: Patients will undergo conventional percutaneous nephrolithotripsy.
|
Conventional PCNL will be performed.
Mini PCNL will be performed.
Ultra-mini PCNL will be performed.
Micro PCNL will be performed.
Retrograde intrarenal surgery will be performed.
|
Active Comparator: Mini PCNL
Endoscopic kidney stone surgery: Patients will undergo mini percutaneous nephrolithotripsy.
|
Conventional PCNL will be performed.
Mini PCNL will be performed.
Ultra-mini PCNL will be performed.
Micro PCNL will be performed.
Retrograde intrarenal surgery will be performed.
|
Active Comparator: Ultra-mini PCNL
Endoscopic kidney stone surgery: Patients will undergo ultra-mini percutaneous nephrolithotripsy.
|
Conventional PCNL will be performed.
Mini PCNL will be performed.
Ultra-mini PCNL will be performed.
Micro PCNL will be performed.
Retrograde intrarenal surgery will be performed.
|
Active Comparator: Micro PCNL
Endoscopic kidney stone surgery: Patients will undergo micro percutaneous nephrolithotripsy.
|
Conventional PCNL will be performed.
Mini PCNL will be performed.
Ultra-mini PCNL will be performed.
Micro PCNL will be performed.
Retrograde intrarenal surgery will be performed.
|
Active Comparator: Retrograde intrarenal surgery
Endoscopic kidney stone surgery: Patients will undergo retrograde intrarenal surgery.
|
Conventional PCNL will be performed.
Mini PCNL will be performed.
Ultra-mini PCNL will be performed.
Micro PCNL will be performed.
Retrograde intrarenal surgery will be performed.
|
Active Comparator: Extracorporeal shock wave lithotripsy
Non-invasive kidney stone treatment: Patients will undergo extracorporeal shock wave lithotripsy.
|
Extracorporeal shock wave will be performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stone-free rate
Time Frame: Within the first 30 days after surgery/procedure
|
Determination of any residual stone in the collecting system by using one of imaging modalities.
|
Within the first 30 days after surgery/procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complication rate
Time Frame: Within the first 30 days after surgery/procedure
|
Determination of any complications related to the surgery/procedure.
|
Within the first 30 days after surgery/procedure
|
Blood Cystatin C level (mg/L)
Time Frame: Within the first 48 hours after surgery/procedure
|
Determination of any impairment in renal function after the surgery/procedure by measuring blood Cystatin C level.
|
Within the first 48 hours after surgery/procedure
|
Blood Netrin-1 level (pg/mL)
Time Frame: Within the first 48 hours after surgery/procedure
|
Determination of any impairment in renal function after the surgery/procedure by measuring blood Netrin-1 level.
|
Within the first 48 hours after surgery/procedure
|
Urine NGAL level (ng/mL)
Time Frame: Within the first 72 hours after surgery/procedure
|
Determination of any impairment in renal function after the surgery/procedure by measuring urine NGAL level.
|
Within the first 72 hours after surgery/procedure
|
Urine Cystatin C level (mg/L)
Time Frame: Within the first 24 hours after surgery/procedure
|
Determination of any impairment in renal function after the surgery/procedure by measuring urine Cystatin C level.
|
Within the first 24 hours after surgery/procedure
|
Urine Netrin-1 level (pg/mL)
Time Frame: Within the first 24 hours after surgery/procedure
|
Determination of any impairment in renal function after the surgery/procedure by measuring urine Netrin-1 level.
|
Within the first 24 hours after surgery/procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Murat Akand, M.D., Selcuk University, School of Medicine, Department of Urology
Publications and helpful links
General Publications
- Desai MR, Sharma R, Mishra S, Sabnis RB, Stief C, Bader M. Single-step percutaneous nephrolithotomy (microperc): the initial clinical report. J Urol. 2011 Jul;186(1):140-5. doi: 10.1016/j.juro.2011.03.029. Epub 2011 May 14.
- Desai J, Solanki R. Ultra-mini percutaneous nephrolithotomy (UMP): one more armamentarium. BJU Int. 2013 Nov;112(7):1046-9. doi: 10.1111/bju.12193. Epub 2013 Jul 11.
- Resorlu B, Unsal A, Gulec H, Oztuna D. A new scoring system for predicting stone-free rate after retrograde intrarenal surgery: the "resorlu-unsal stone score". Urology. 2012 Sep;80(3):512-8. doi: 10.1016/j.urology.2012.02.072. Epub 2012 Jul 26.
- Cepeda M, Amon JH, Mainez JA, Rodriguez V, Alonso D, Martinez-Sagarra JM. Flexible ureteroscopy for renal stones. Actas Urol Esp. 2014 Nov;38(9):571-5. doi: 10.1016/j.acuro.2014.03.014. Epub 2014 Jun 2. English, Spanish.
- Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petrik A, Turk C. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.
- Aboumarzouk OM, Monga M, Kata SG, Traxer O, Somani BK. Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol. 2012 Oct;26(10):1257-63. doi: 10.1089/end.2012.0217. Epub 2012 Jul 30.
- Resorlu B, Unsal A, Ziypak T, Diri A, Atis G, Guven S, Sancaktutar AA, Tepeler A, Bozkurt OF, Oztuna D. Comparison of retrograde intrarenal surgery, shockwave lithotripsy, and percutaneous nephrolithotomy for treatment of medium-sized radiolucent renal stones. World J Urol. 2013 Dec;31(6):1581-6. doi: 10.1007/s00345-012-0991-1. Epub 2012 Nov 22.
- de la Rosette J, Assimos D, Desai M, Gutierrez J, Lingeman J, Scarpa R, Tefekli A; CROES PCNL Study Group. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol. 2011 Jan;25(1):11-7. doi: 10.1089/end.2010.0424.
- Kamphuis GM, Baard J, Westendarp M, de la Rosette JJ. Lessons learned from the CROES percutaneous nephrolithotomy global study. World J Urol. 2015 Feb;33(2):223-33. doi: 10.1007/s00345-014-1367-5. Epub 2014 Aug 7.
- Bader MJ, Gratzke C, Seitz M, Sharma R, Stief CG, Desai M. The "all-seeing needle": initial results of an optical puncture system confirming access in percutaneous nephrolithotomy. Eur Urol. 2011 Jun;59(6):1054-9. doi: 10.1016/j.eururo.2011.03.026. Epub 2011 Apr 1.
- Hatipoglu NK, Tepeler A, Buldu I, Atis G, Bodakci MN, Sancaktutar AA, Silay MS, Daggulli M, Istanbulluoglu MO, Karatag T, Gurbuz C, Armagan A, Caskurlu T. Initial experience of micro-percutaneous nephrolithotomy in the treatment of renal calculi in 140 renal units. Urolithiasis. 2014 Apr;42(2):159-64. doi: 10.1007/s00240-013-0631-2. Epub 2013 Dec 13.
- Gao X, Peng Y, Shi X, Li L, Zhou T, Xu B, Sun Y. Safety and efficacy of retrograde intrarenal surgery for renal stones in patients with a solitary kidney: a single-center experience. J Endourol. 2014 Nov;28(11):1290-4. doi: 10.1089/end.2014.0295. Epub 2014 Aug 6.
- Palmero JL, Miralles J, Garau C, Nuno de la Rosa I, Amoros A, Benedicto A. Retrograde intrarenal surgery (RIRS) in the treatment of calyceal diverticulum with lithiasis. Arch Esp Urol. 2014 May;67(4):331-6. English, Spanish.
- Wong KA, Sahai A, Patel A, Thomas K, Bultitude M, Glass J. Is percutaneous nephrolithotomy in solitary kidneys safe? Urology. 2013 Nov;82(5):1013-6. doi: 10.1016/j.urology.2013.06.034. Epub 2013 Aug 16.
- De S, Autorino R, Kim FJ, Zargar H, Laydner H, Balsamo R, Torricelli FC, Di Palma C, Molina WR, Monga M, De Sio M. Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis. Eur Urol. 2015 Jan;67(1):125-137. doi: 10.1016/j.eururo.2014.07.003. Epub 2014 Jul 23. Erratum In: Eur Urol. 2016 Apr;69(4):e85.
- Bas O, Bakirtas H, Sener NC, Ozturk U, Tuygun C, Goktug HN, Imamoglu MA. Comparison of shock wave lithotripsy, flexible ureterorenoscopy and percutaneous nephrolithotripsy on moderate size renal pelvis stones. Urolithiasis. 2014 Apr;42(2):115-20. doi: 10.1007/s00240-013-0615-2. Epub 2013 Oct 27.
- Ozturk U, Sener NC, Goktug HN, Nalbant I, Gucuk A, Imamoglu MA. Comparison of percutaneous nephrolithotomy, shock wave lithotripsy, and retrograde intrarenal surgery for lower pole renal calculi 10-20 mm. Urol Int. 2013;91(3):345-9. doi: 10.1159/000351136. Epub 2013 Jun 28.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU-PCNL-LPRPS-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stones
-
Indiana Kidney Stone InstituteUniversity of Washington; VA Puget Sound Health Care SystemCompleted
-
Omeros CorporationCompletedUrinary Calculi | Renal Calculi | Kidney Stones | Urinary Stones | Urinary Tract StonesUnited States
-
Mayo ClinicCompletedKidney Calculi | Nephrolithiasis | Kidney Stones | Renal StonesUnited States, Canada
-
United States Naval Medical Center, San DiegoUnknown
-
University of British ColumbiaPercutaneous Systems, Inc.Completed
-
Robert SworWilliam Beaumont HospitalsCompletedKidney Stones | Ureteral StonesUnited States
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
-
Mansoura UniversityRecruitingUrinary Stones | Renal StoneEgypt
-
Services Hospital, LahoreCompleted
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingNephrolithiasis | Urolithiasis | Kidney Stones | Ureter StonesUnited States
Clinical Trials on Endoscopic kidney stone surgery
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeyUnknown
-
Indiana Kidney Stone InstituteIndiana University School of MedicineCompleted
-
EndoTheiaVanderbilt University Medical CenterEnrolling by invitation
-
Indiana Kidney Stone InstituteUniversity of Washington; VA Puget Sound Health Care SystemCompleted
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedCystinuria | Primary Hyperoxaluria | Dent Disease | Adenine Phosphoribosyl Transferase DeficiencyUnited States, Iceland
-
Marmara UniversityRecruitingKidney Calculi | Ureteroscopy | Nephrolithotomy, PercutaneousTurkey
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruiting
-
Helsinki University Central HospitalActive, not recruitingAsthma | Nasal Polyps | Aspirin Sensitivity | Sinusitis, ChronicFinland, Netherlands